Jupiter Neurosciences, Inc. Warrants (JUNSW) Peer Comparison
$0.00
$--
(--%)
As on 08-Feb-2022EDT
Market cap
$-- Mln
Revenue (TTM)
$-- Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Edit
| Jupiter Neurosciences, Inc. Warrants (JUNSW) | Zai Lab - ADR | Mesoblast - ADR | HUTCHMED (China) - ADR | Inventiva Sa (IVA) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
-- | 2,928 | 2,262 | 2,152 | 1,111 |
Revenue ($ Mln) |
1 | 450 | 120 | 549 | 4 |
Net Profit ($ Mln) |
-1.65 | -188.21 | -57.50 | 17.88 | -340.16 |
Net Margin (%) |
-- | -41.86 | -144.33 | 3.26 | -540.52 |
RoE (%) |
37.92 | -28.46 | -9.86 | 1.43 | 501.41 |
Price to Earnings |
-- | -- | -- | 123.80 | -- |
Price-To-Book |
-- | 4.96 | 4.15 | 1.71 | 2.10 |
Income Statement ($ Mln)
| Jupiter Neurosciences, Inc. Warrants (JUNSW) | Zai Lab - ADR | Mesoblast - ADR | HUTCHMED (China) - ADR | Inventiva Sa (IVA) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
1.13 | 48.96 | 32.16 | 227.98 | 0.37 |
|
Cost of Revenue
|
-- | 239.45 | 81.50 | 188.52 | 0.85 |
|
Gross Profit
|
-- | -190.49 | -49.34 | 39.46 | 0.37 |
|
Operating Expenses
|
2.98 | 111.31 | 107.56 | 236.13 | 30.09 |
|
Operating Profit (EBIT)
|
-1.85 | -301.80 | -74.87 | -198.62 | -29.72 |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
-1.65 | -268.91 | -87.36 | -110.88 | -33.62 |
|
Provision for Tax
|
-- | 30.38 | -9.42 | 4.83 | -2.00 |
|
Profit after Tax (Net Income)
|
-1.65 | -268.91 | -77.94 | -125.73 | -31.62 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
-- | -268.91 | -77.94 | -125.73 | -33.62 |
Liabilities ($ Mln)
| Jupiter Neurosciences, Inc. Warrants (JUNSW) | Zai Lab - ADR | Mesoblast - ADR | HUTCHMED (China) - ADR | Inventiva Sa (IVA) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
-3.71 | 1,169.35 | 549.33 | 484.12 | 111.21 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
0.00 | 30.25 | 94.13 | 46.77 | 13.80 |
|
Current Liabilities
|
4.26 | 98.04 | 90.14 | 158.40 | 13.91 |
|
Total Liabilities
|
0.55 | 1,297.64 | 733.60 | 724.12 | 138.92 |
Assets ($ Mln)
| Jupiter Neurosciences, Inc. Warrants (JUNSW) | Zai Lab - ADR | Mesoblast - ADR | HUTCHMED (China) - ADR | Inventiva Sa (IVA) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
0.00 | 81.60 | 597.05 | 193.38 | 5.92 |
|
Current Assets
|
0.55 | 1,216.04 | 136.55 | 530.74 | 133.00 |
|
Total Assets
|
0.55 | 1,297.64 | 733.60 | 724.12 | 138.92 |
|
Total Debt*
|
0.11 | 18.60 | 99.31 | 38.90 | 10.06 |
|
Net Current Assets
|
-3.71 | 1,117.99 | 46.41 | 372.34 | 119.09 |
Cashflow ($ Mln)
| Jupiter Neurosciences, Inc. Warrants (JUNSW) | Zai Lab - ADR | Mesoblast - ADR | HUTCHMED (China) - ADR | Inventiva Sa (IVA) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-0.25 | -216.06 | -56.37 | -62.07 | -30.59 |
|
Cash Flow from Investing Activities
|
-- | -554.83 | -3.27 | -125.44 | -8.56 |
|
Cash from Financing Activities
|
0.46 | 1,132.44 | 137.04 | 296.43 | 111.67 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Jupiter Neurosciences, Inc. Warrants (JUNSW) | Zai Lab - ADR | Mesoblast - ADR | HUTCHMED (China) - ADR | Inventiva Sa (IVA) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
44.66 | -35.75 | -12.87 | -29.78 | -38.86 |
|
ROE (%)
|
37.92 | -36.74 | -15.13 | -32.57 | -41.44 |
|
ROA (%)
|
-595.04 | -32.54 | -11.25 | -21.14 | -32.29 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
-146.92 | -549.26 | -242.38 | -55.15 | -8,500.81 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Jupiter Neurosciences, Inc. Warrants (JUNSW) | Zai Lab - ADR | Mesoblast - ADR | HUTCHMED (China) - ADR | Inventiva Sa (IVA) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-- | 2.77 | 0.92 | 0.11 | -0.95 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
45.69 | -46.65 | 13.21 | -18.59 | -4.64 |
|
EPS Growth (%)
|
-- | -0.14 | 0.20 | -4.46 | 0.27 |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Jupiter Neurosciences, Inc. Warrants (JUNSW) | Zai Lab - ADR | Mesoblast - ADR | HUTCHMED (China) - ADR | Inventiva Sa (IVA) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-- | -440.53 | -7.95 | -36.83 | -17.57 |
|
Price / Book Value
|
-- | 101.30 | 1.13 | 9.57 | 5.00 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-- | -394.71 | -8.55 | -22.22 | -16.27 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Jupiter Neurosciences, Inc. Warrants (JUNSW) | Zai Lab - ADR | Mesoblast - ADR | HUTCHMED (China) - ADR | Inventiva Sa (IVA) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
-0.03 | 0.02 | 0.18 | 0.08 | 0.09 |
|
Short term debt to equity ratio
|
-0.03 | 0.00 | 0.07 | 0.01 | 0.00 |
|
Current Ratio
|
0.13 | 12.40 | 1.51 | 3.35 | 9.56 |
|
Quick Ratio
|
-- | 12.27 | 1.52 | 3.23 | 9.54 |
|
Interest Coverage
|
-- | -1,667.41 | -4.94 | -249.90 | -450.27 |
Operating Efficiency Ratios
| Jupiter Neurosciences, Inc. Warrants (JUNSW) | Zai Lab - ADR | Mesoblast - ADR | HUTCHMED (China) - ADR | Inventiva Sa (IVA) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
11.21 | 10.55 | 4.11 | 21.00 | 12.90 |
|
Asset Turnover
|
4.05 | 0.06 | 0.05 | 0.38 | 0.00 |
|
Receivable days
|
40.94 | 33.41 | 17.40 | 100.17 | 339.23 |
|
Inventory Days
|
-- | 14.60 | -1.12 | 34.85 | 152.62 |
|
Payable days
|
-- | 65.06 | 85.23 | 53.84 | 3,111.53 |
|
Cash Conversion Cycle
|
-- | -17.05 | -68.95 | 81.18 | -2,619.68 |
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
